Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives

Katharine A. Seton(Norwich Research Park), Jesper Mehlsen(Frederiksberg Hospital), Karen Giménez-Orenga(Universitat de València), José Espejo(Max Delbrück Center), Rik Haagmans(University of East Anglia), Donia Jamal Ramadan(Oslo University Hospital)

Journal of Clinical Medicine

January 6, 2024

10.3390/jcm13020325

Cited by 32

Related Papers

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

|The Lancet|2003|3.8k

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

|The Lancet|2005|2.9k

Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease

|Pharmaceuticals|2021|43

HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms

|Frontiers in Immunology|2022|41

MYC Induces a Hybrid Energetics Program Early in Cell Reprogramming

|Stem Cell Reports|2018|37